Question special
Lead Moderator

Sanoe brings up several important points for discussion. Let’s start with the need for improved insulin pharmacokinetic properties that would allow for a faster onset of action. How critical would this be to the success of the bionic pancreas? What efforts are currently ongoing on this regard?